Sarcoidosis and inclusion body myositis

Rheumatology

Volumn 47, Issue 9, 2008, Pages 1433-1435

  Vattemi, G ^a   Tonin, P ^a   Marini, M ^a   Guadagnin, M L ^b   Dal Pra, B ^b   Simonati, A ^a   Filosto, M ^c   Tomelleri, Giuliano ^a  

^a Section of Clinical Neurology   (Italy)

^b Hospital of Thiene   (Italy)

^c SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; PREDNISONE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DRUG TREATMENT FAILURE; ELECTROMYOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; LETTER; LUNG SARCOIDOSIS; LYMPHADENOPATHY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOTOR DYSFUNCTION; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; NERVE BIOPSY; POLYNEUROPATHY; PRIORITY JOURNAL; REFLEX DISORDER; SARCOIDOSIS; TENDON REFLEX; THORAX RADIOGRAPHY; THORAX SCINTISCANNING;

BIOPSY; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; SARCOIDOSIS;

EID: 50849087368     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken252     Document Type: Letter

References (11)

1. Fayad F, Liotè F, Berenbaum F, Orcel P, Bardin T. Muscle involvement in sarcoidosis: A retrospective and follow up studies. J Rheumatol 2006;33:98-103.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007; 357:2153-65.
3. Danon MJ, Perurena OH, Ronan S, Manaligod JR. Inclusion body myositis associated with systemic sarcoidosis. Can J Neurol Sci 1986;13:334-6.
4. Bouillot S, Coquet M, Ferrer X, Lagueny A, Leroy JP, Vital C. Inclusion body myositis associated with sarcoidosis: A report of 3 cases. Ann Pathol 2001;21:334-6.
5. Mikol J, Engel AG. Inclusion body myositis. In: Engel AG, Franzini-Amstrong C, eds. Myology. New York: McGraw-Hill, 1994;1367-88.
6. Mhiri C, Gherardi R. Inclusion body myositis in French patients. A clinicopathological evaluation. Neuropathol Appl Neurobiol 1990;16:333-4.
7. Koffman BM, Rugiero M, Dalakas MC. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 1998;21:115-7.
8. Badrising UA, Schreuder GM, Giphart MJ et al. Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology 2004; 63:2396-8.
9. De Paepe B, De Keyzer K, Martin JJ, De Bleecker JL. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies. Acta Neuropathol 2005;109:576-82.
10. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis. Observation in 40 patients. Brain 1989;112:727-47.
11. McCoy AL, Bubb MR, Plotz PH, Davis JC. Inclusion body myositis long after dermatomyositis: A report of two cases. Clin Exp Rheumatol 1999;17:235-9.